San Jose, CA -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), has announced the launch of the BD FACSJazz Cell Sorting System, a flow cytometer that simplifies cellular isolation and analysis for researchers requiring high sample integrity. The sorter occupoes 20” x 20” (51 cm x 51 cm) of benchtop space and is ideal for genomic studies. The system is capable of identifying, characterizing and isolating single or multiple cells and depositing them in 96 and 384 well plates with precision, accuracy and rapidity.
-----
PRESS RELEASE
New, Affordable Flow Cytometer Cell Sorter Expands Access to Wider Range of Life Science Applications
BD Biosciences Launches BD FACSJazz™ Cell Sorting System
San Jose, CA – BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the BD FACSJazz™ Cell Sorting System, a next-generation flow cytometer that simplifies cellular isolation and analysis for researchers requiring high sample integrity. Occupying 20” x 20” (51 cm x 51 cm) of benchtop space, the new sorter features high sensitivity to identify and isolate target cells for up to eight parameters.
“As a leader in cell analysis, BD’s goal is to make advanced cell isolation and sorting accessible to all researchers, with all levels of experience,” said Alberto Mas, Worldwide President, BD Biosciences. “The BD FACSJazz Cell Sorting System offers, for the first time, an extremely powerful tool for the identification and isolation of single or multiple cells even from complex or extremely rare cell populations right from the benchtop. With application across a number of applications, we believe that this product will complement the recent and very rapid advances in genomic studies where sample integrity is critical for next-generation sequencing and sequence detection.”
The new BD FACSJazz Cell Sorting System will have broad utility for next-generation genomic studies. The system is capable of identifying, characterizing and isolating single or multiple cells and depositing them in 96 and 384 well plates with precision, accuracy and rapidity.
The BD FACSJazz Cell Sorting System incorporates customer input from a 2011 global early access program. As a result, refinements were made to enhance usability and ease of use. In addition, a violet laser and pulse processing were added to the offering to enhance live dead cell discrimination and cell cycle analysis.
The system has many innovative features that simplify sorting such as digital controls and factory-optimized settings for the precise isolation of cells. In addition, the intuitive BD FACS Sortware was developed explicitly for cell sorting to simplify workflow to isolate cells into tubes, or plates as single or multiple cells.
The BD FACSJazz Cell Sorting System can be configured to support up to six colors with eight parameters. This system includes a standard blue laser but can be additionally configured with an optional red and/or a violet laser. It is also available with an optional, custom-designed biological safety cabinet. The custom enclosure has beenverified by Baker Company to meet personnel and product protection standards for both a Class II Type A2 biosafety cabinet and National Sanitation Foundation International Standard 49.
For more information on the BD FACSJazz Cell Sorting System, please visit www.bdbiosciences.com/facsjazz.
About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.
-----
Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn
Follow OptoIQ on your iPhone; download the free app here.
Subscribe now to BioOptics World magazine; it's free!
